PubRank

F J Seidler

Author PubWeight™ 143.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol 1998 2.58
2 Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol 1995 2.47
3 Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol 1997 2.42
4 Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res 2001 1.90
5 Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull 1997 1.88
6 Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology 1998 1.83
7 Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res 1998 1.60
8 Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res Dev Brain Res 2000 1.58
9 Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect 2001 1.57
10 An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res 2000 1.51
11 Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull 1998 1.48
12 Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res 1999 1.48
13 Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 1999 1.40
14 Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res 2001 1.39
15 Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 2001 1.36
16 Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in cell replication and differentiation. Brain Res 2000 1.34
17 Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J Physiol 1985 1.32
18 Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res 2002 1.29
19 Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2000 1.25
20 Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 2001 1.21
21 Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Brain Res Dev Brain Res 2000 1.20
22 Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res 2001 1.20
23 Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J Dev Physiol 1988 1.13
24 Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther 1989 1.13
25 Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology 1997 1.10
26 Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Brain Res Dev Brain Res 2002 1.09
27 Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull 1989 1.09
28 Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res 2000 1.06
29 Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 1998 1.05
30 Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res 2000 1.05
31 Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull 1995 1.05
32 Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther 2007 1.05
33 Ontogeny of adrenomedullary responses to hypoxia and hypoglycemia: role of splanchnic innervation. Brain Res Bull 1986 1.05
34 Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr Res 1988 1.02
35 Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res 2000 1.02
36 Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest 1994 1.01
37 Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Brain Res Dev Brain Res 2001 0.97
38 Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry 1997 0.97
39 Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding. Neurotoxicol Teratol 1993 0.95
40 Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol 1997 0.95
41 Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res 2002 0.94
42 Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther 1987 0.93
43 Ontogeny of histaminergic neurotransmission in the rat brain: concomitant development of neuronal histamine, H-1 receptors, and H-1 receptor-mediated stimulation of phospholipid turnover. J Neurochem 1981 0.93
44 Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. J Dev Physiol 1992 0.92
45 Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther 1988 0.92
46 Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res 1991 0.90
47 Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. J Mol Cell Cardiol 1999 0.90
48 Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther 1999 0.89
49 Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology 1993 0.89
50 Cardiac alpha-adrenergic receptor expression is regulated by thyroid hormone during a critical developmental period. J Mol Cell Cardiol 1996 0.89
51 Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Res Dev Brain Res 1996 0.88
52 Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Brain Res Dev Brain Res 1999 0.88
53 Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc Natl Acad Sci U S A 1990 0.88
54 Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res 2000 0.88
55 Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Brain Res Dev Brain Res 1999 0.88
56 Non-neurogenic mechanism for reserpine-induced release of catecholamines from the adrenal medulla of neonatal rats: possible modulation by opiate receptors. Neuroscience 1982 0.87
57 Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. Neuroscience 1981 0.87
58 Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor down-regulation. Pediatr Res 1996 0.86
59 Ontogeny of (--)-[3H]norepinephrine uptake properties of synaptic storage vesicles of rat brain. Brain Res 1978 0.86
60 Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr Res 1994 0.86
61 Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Brain Res Dev Brain Res 2001 0.86
62 Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated cell signaling in brain and heart of neonatal rats. Brain Res 2001 0.86
63 Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate 1992 0.86
64 Prenatal nicotine exposure impairs beta-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull 1990 0.85
65 Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res 1990 0.84
66 Non-neurogenic adrenal catecholamine release in the neonatal rat: exocytosis or diffusion? Brain Res 1986 0.84
67 Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res Bull 1993 0.84
68 Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res 1997 0.84
69 Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 1992 0.84
70 Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Brain Res Dev Brain Res 1998 0.83
71 Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins. Neurotoxicol Teratol 1993 0.83
72 Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. Brain Res Bull 1986 0.83
73 Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Brain Res Dev Brain Res 1992 0.83
74 Stimulation of ornithine decarboxylase by histamine or norepinephrine in brain regions of the developing rat: evidence for biogenic amines as trophic agents in neonatal brain development. Life Sci 1983 0.83
75 Histamine stimulates brain phospholipid turnover through a direct, H-1 receptor-mediated mechanism. Life Sci 1980 0.83
76 Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the pre-weanling rat. Br J Pharmacol 1979 0.82
77 Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull 1998 0.82
78 Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems. Life Sci 1984 0.82
79 Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney. Teratology 1992 0.82
80 Differential development of cholinergic nerve terminal markers in rat brain regions: implications for nerve terminal density, impulse activity and specific gene expression. Brain Res 1993 0.82
81 Rat brain synaptic vesicles: uptake specificities of [3H]norepinephrine and [3H]serotonin in preparations from whole brain and brain regions. J Neurochem 1978 0.82
82 Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain. Brain Res Dev Brain Res 1997 0.81
83 Combining 'caged-dopamine' photolysis with fast-scan cyclic voltammetry to assess dopamine clearance and release autoinhibition in vitro. J Neurosci Methods 1996 0.81
84 Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. Teratology 1991 0.81
85 Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol 1994 0.81
86 Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci 1990 0.81
87 Sex-related spatial learning differences after prenatal cocaine exposure in the young adult rat. Neurotoxicology 1993 0.80
88 Persistent c-fos induction by nicotine in developing rat brain regions: interaction with hypoxia. Pediatr Res 1999 0.80
89 Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat. Brain Res Bull 1991 0.80
90 Neonatal central catecholaminergic lesions with intracisternal 6-hydroxydopamine: effects on development of presynaptic and postsynaptic components of peripheral sympathetic pathways and on the ornithine decarboxylase/polyamine system in heart, lung and kidney. J Pharmacol Exp Ther 1988 0.80
91 Dexamethasone treatment in utero enhances neonatal cholinergic nerve terminal development in rat brain. Res Commun Chem Pathol Pharmacol 1993 0.80
92 Acute and chronic effects of nicotine on synthesis and storage of catecholamines in the rat adrenal medulla. Life Sci 1975 0.80
93 High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann N Y Acad Sci 1996 0.80
94 Chronic prenatal nicotine exposure sensitizes rat brain to acute postnatal nicotine challenge as assessed with ornithine decarboxylase. Life Sci 1991 0.79
95 Acute stimulation of ornithine decarboxylase in neonatal rat brain regions by nicotine: a central receptor-mediated process? Brain Res Dev Brain Res 1991 0.79
96 Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat. Psychopharmacology (Berl) 1998 0.79
97 Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein. Ann N Y Acad Sci 1991 0.79
98 Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci 1991 0.79
99 Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. J Pharmacol Exp Ther 1982 0.79
100 Pituitary-thyroid axis reactivity to hyper- and hypothyroidism in the perinatal period: ontogeny of regulation of regulation and long-term programming of responses. J Dev Physiol 1992 0.79
101 Adolescent nicotine exposure alters cardiac autonomic responsiveness: beta-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. Brain Res 2000 0.79
102 Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. J Pharmacol Exp Ther 1982 0.79
103 Fetal terbutaline exposure causes selective postnatal increases in cerebellar alpha-adrenergic receptor binding. Life Sci 1990 0.79
104 Fetal dexamethasone exposure affects basal ornithine decarboxylase activity in developing rat brain regions and alters acute responses to hypoxia and maternal separation. Biol Neonate 1991 0.79
105 Glucocorticoid-targeting of the adenylyl cyclase signaling pathway in the cerebellum of young vs. aged rats. Brain Res 1998 0.79
106 Neuronal control of cardiac and hepatic macromolecule synthesis in the neonatal rat: effects of sympathectomy. Pediatr Res 1997 0.79
107 Delays in growth and biochemical development of rat brain caused by maternal methadone administration: are the alterations in synaptogenesis and cellular maturation independent of reduced maternal food intake? Dev Neurosci 1982 0.78
108 Dose-dependent effect of prenatal dexamethasone treatment on beta-adrenergic receptor coupling to ornithine decarboxylase and cyclic AMP. J Dev Physiol 1990 0.78
109 Perinatal exposure to environmental tobacco smoke alters cell signaling in a primate model: autonomic receptors and the control of adenylyl cyclase activity in heart and lung. Brain Res Dev Brain Res 2000 0.78
110 Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res 1996 0.78
111 Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. J Pharmacol Exp Ther 1982 0.78
112 Effects of chronic nicotine administration on the denervated rat adrenal medulla. Br J Pharmacol 1976 0.78
113 Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum. Brain Res Bull 1990 0.78
114 Heroin neuroteratogenicity: targeting adenylyl cyclase as an underlying biochemical mechanism. Brain Res Dev Brain Res 2001 0.78
115 Neonatal methylmercury poisoning in the rat: effects on development of central catecholamine neurotransmitter systems. Toxicol Appl Pharmacol 1982 0.78
116 Antimitotic and cytotoxic effects of theophylline in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2000 0.78
117 Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: a critical period for regionally selective alterations? Teratology 1992 0.78
118 Effects of chronic chlorisondamine administration on the sympatho-adrenal axis. Biochem Pharmacol 1976 0.78
119 Perinatal dietary exposure to soy lecithin: altered sensitivity to central cholinergic stimulation. Int J Dev Neurosci 1986 0.77
120 Beta-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization. Am J Physiol Regul Integr Comp Physiol 2002 0.77
121 Development of alpha-noradrenergic and Dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain. J Neurochem 1981 0.77
122 Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways. Neuropharmacology 1993 0.77
123 Glucocorticoids accelerate the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: promotion by prenatal exposure to a low dose of dexamethasone. J Dev Physiol 1992 0.77
124 Effects of maternal methadone administration on ornithine decarboxylase in brain and heart of the offspring: relationships of enzyme activity to dose and to growth impairment in the rat. Life Sci 1980 0.77
125 Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? Teratology 1995 0.77
126 Expression of mRNAs coding for the transforming growth factor-beta receptors in brain regions of euthyroid and hypothyroid neonatal rats and in adult brain. Brain Res Dev Brain Res 1997 0.77
127 Perinatal methadone addiction affects brain synaptic development of biogenic amine systems in the rat. Life Sci 1979 0.77
128 Stress in the fetus and newborn. Adv Exp Med Biol 1988 0.77
129 Beta-adrenergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. Toxicol Appl Pharmacol 1995 0.77
130 Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 1991 0.77
131 Dose-dependent glucocorticoid effects on noradrenergic synaptogenesis in rat brain: ontogeny of [3H]desmethylimipramine binding sites after fetal exposure to dexamethasone. Res Commun Chem Pathol Pharmacol 1991 0.77
132 Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? Toxicol Appl Pharmacol 1994 0.77
133 Beta-adrenoceptor-mediated cell signaling in the neonatal heart and liver: responses to terbutaline. Am J Physiol Regul Integr Comp Physiol 2001 0.77
134 Effects of prenatal reserpine administration on development of the rat adrenal medulla and central nervous system. J Pharmacol Exp Ther 1976 0.77
135 Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry 1996 0.77
136 Are developing beta-adrenoceptors able to desensitize? Acute and chronic effects of beta-agonists in neonatal heart and liver. Am J Physiol Regul Integr Comp Physiol 2002 0.77
137 Regional differences in brain monoamine oxidase subtypes in an animal model of geriatric depression: effects of olfactory bulbectomy in young versus aged rats. Brain Res 2000 0.77
138 Presynaptic input regulates development of beta-adrenergic control of rat brain ornithine decarboxylase: effects of 6-hydroxydopamine or propranolol. Brain Res Bull 1991 0.76
139 Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Brain Res Dev Brain Res 1995 0.76
140 Effects of fetal dexamethasone exposure on postnatal control of cardiac adenylate cyclase: beta-adrenergic receptor coupling to Gs regulatory protein. Teratology 1993 0.76
141 Beta-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 1995 0.76
142 Effects of MK-801 on DNA synthesis in neonatal rat brain regions under normoxic and hypoxic conditions. Brain Res Dev Brain Res 1991 0.76
143 Regulation of fetal cardiac and hepatic beta-adrenoceptors and adenylyl cyclase signaling: terbutaline effects. Am J Physiol Regul Integr Comp Physiol 2001 0.76
144 Development of the linkage of beta-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine. J Dev Physiol 1989 0.76
145 Role of sympathetic neurons in development of beta-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment. J Dev Physiol 1989 0.76
146 Agonist-induced sensitization of beta-adrenoceptor signaling in neonatal rat heart: expression and catalytic activity of adenylyl cyclase. J Pharmacol Exp Ther 1999 0.76
147 Effect of transient hypoxia on oxygenation of the developing rat brain: relationships among haemoglobin saturation, autoregulation of blood flow and mitochondrial redox state. J Dev Physiol 1989 0.76
148 Ontogeny of beta-adrenoceptor/adenylyl cyclase desensitization mechanisms: the role of neonatal innervation. Brain Res 1996 0.76
149 Neonatal polyamine depletion by alpha-difluoromethylornithine: effects on adenylyl cyclase cell signaling are separable from effects on brain region growth. Brain Res 2000 0.76
150 Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure. Brain Res Bull 1993 0.76
151 Neonatal chlorpyrifos administration elicits deficits in immune function in adulthood: a neural effect? Brain Res Dev Brain Res 2001 0.75
152 Cocaine exacerbates hypoxia-induced cell damage in the developing brain: effects on ornithine decarboxylase activity and protein synthesis. Biol Neonate 1994 0.75
153 Norepinephrine content of the rat kidney during development: alterations induced by perinatal methadone. Life Sci 1982 0.75
154 Toxic effects of maternal methadone administration on cardiac development in the neonatal rat: potential participation of altered polyamine levels in growth impairment. Toxicol Lett 1982 0.75
155 Acute effects of cocaine on ornithine decarboxylase activity in fetal and neonatal rat heart: evidence for cardiotoxicity. Biol Neonate 1993 0.75
156 Catecholamine synthesis, storage and release in adrenal medulla and whole brain during acute and chronic methadone administration. Biochem Pharmacol 1976 0.75
157 Fetal dexamethasone exposure sensitizes neonatal rat brain to hypoxia: effects on protein and DNA synthesis. Brain Res Dev Brain Res 1991 0.75
158 Adrenergic control of DNA synthesis in developing rat brain regions: effects of intracisternal administration of isoproterenol. Brain Res Bull 1988 0.75
159 Release of [3H]norepinephrine from synaptic vesicles isolated from rat brain after the intracisternal administration of [3H]norepinephrine: influence of nucleotides, ions and drugs, and destabilization of transmitter storage caused by acute or chronic lithium administration. Neuroscience 1980 0.75
160 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase. Neurosci Lett 1992 0.75
161 Transient postnatal elevation of norepinephrine content and turnover in brain regions of rats exposed to terbutaline prenatally: evidence for autoregulation of noradrenergic development? Res Commun Chem Pathol Pharmacol 1992 0.75
162 Overexpression of alpha 2-adrenergic receptors in fetal rat heart: receptors in search of a function. J Dev Physiol 1992 0.75
163 Precocious development of sympatho-adrenal function in rats whose mothers received methadone. Life Sci 1980 0.75
164 A critical period for the role of thyroid hormone in development of renal alpha-adrenergic receptors. Pediatr Res 1997 0.75
165 beta Adrenergic control of c-fos protooncogene expression in developing rat brain regions. J Pharmacol Exp Ther 1994 0.75
166 Toxic effects of hypoxia on neonatal cardiac function in the rat: alpha-adrenergic mechanisms. Toxicol Lett 1987 0.75
167 Methadone inhibits serotonin and norephinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro but not in vivo. Eur J Pharmacol 1978 0.75
168 beta-Adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart. Am J Physiol Regul Integr Comp Physiol 2002 0.75
169 Uptake of (-) 3H-norepinephrine by storage vesicles prepared from whole rat brain: properties of the uptake system and its inhibition by drugs. Life Sci 1977 0.75
170 Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase. Res Commun Chem Pathol Pharmacol 1991 0.75
171 Maturation of sympathetic neurotransmission in the rat heart. VI. The effect of neonatal central catecholaminergic lesions. J Pharmacol Exp Ther 1980 0.75
172 Ontogeny of G-protein expression: control by beta-adrenoceptors. Brain Res Dev Brain Res 2000 0.75
173 Modulation of hepatic adrenergic receptor ontogeny by thyroid hormone. Res Commun Mol Pathol Pharmacol 1995 0.75
174 Alteration by methadone of catecholamine uptake and release in isolated rat adrenomedullary storage vesicles. Life Sci 1976 0.75
175 Role of ornithine decarboxylase and the polyamines in nervous system development: Short-term postnatal administration of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Int J Dev Neurosci 1983 0.75
176 Aging and glucocorticoids: effects on cell signaling mediated through adenylyl cyclase. J Pharmacol Exp Ther 1996 0.75
177 Role of thyroid status in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase, ornithine decarboxylase and c-fos protooncogene expression. J Pharmacol Exp Ther 1994 0.75
178 Alterations in the development of catecholamine turnover induced by perinatal methadone: differences in central vs. peripheral sympathetic nervous systems. Life Sci 1981 0.75
179 The developmental switch in ventricular myosin expression in vivo is not triggered by an increase in cyclic AMP. Reprod Fertil Dev 1995 0.75
180 Morphine-reserpine interactions in the adrenal medulla. Toxicol Appl Pharmacol 1976 0.75
181 Critical periods for the role of ornithine decarboxylase and the polyamines in growth and development of the rat: Effects of exposure to α-difluoromethylornithine during discrete prenatal or postnatal intervals. Int J Dev Neurosci 1983 0.75
182 Can intracellular signalling pathways predict developmental abnormalities? Biomarkers 1996 0.75
183 Ontogenetic transition of cardiac myosin heavy chain isoforms in rat ventricle: effects of fetal exposure to beta-adrenergic agonists or antagonists. J Dev Physiol 1992 0.75
184 Dual control of DNA synthesis by alpha- and beta-adrenergic mechanisms in normoxic and hypoxic neonatal rat brain. Brain Res Dev Brain Res 1990 0.75
185 Generation of reactive oxygen species by xanthine derivatives in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2001 0.75
186 Adolescent nicotine: deficits in immune function. Brain Res Dev Brain Res 2001 0.75
187 Age-dependence of inhibition of rat brain synaptic vesicle [3H]norepinephrine uptake caused by administration of a single dose of reserpine: persistence of inhibition in adults but not in neonates. J Pharmacol Exp Ther 1978 0.75
188 Ionic and nucleotide cofactor requirements for uptake of [3H]norepinephrine by rat brain synaptic vesicle preparations. Mol Pharmacol 1978 0.75
189 Macromolecular levels, DNA synthesis and ornithine decarboxylase activity in leg muscles from 6-mercaptopurine-treated rats. Toxicol Ind Health 1986 0.75
190 Prenatal cocaine eliminates the sex-dependent differences in activation observed in adult rats after cocaine challenge. Brain Res Bull 1994 0.75
191 Structural characteristics for inhibition of [3H] norepinephrine uptake into rat brain synaptic vesicles by beta-carboline, indolealkylamine, phenethylamine and n-alkylamine derivatives. Mol Pharmacol 1979 0.75
192 Immediate decline in DNA synthesis in neonatal rat lung caused by exposure to 100% oxygen. Res Commun Chem Pathol Pharmacol 1993 0.75
193 Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase and c-fos protooncogene expression. J Pharmacol Exp Ther 1995 0.75
194 Maternal methadone administration: deficit in development of alpha-noradrenergic responses in developing rat brain as assessed by norepinephrine stimulation of 33Pi incorporation into phospholipids in vivo. Biochem Pharmacol 1982 0.75
195 Developmental shift from local to central control of norepinephrine release in the cardiac-sympathetic axis: effects of cocaine and related drugs. J Pharmacol Exp Ther 1991 0.75
196 Neural factors in the development of renal function: effect of neonatal central catecholaminergic lesions with 6-hydroxydopamine. J Dev Physiol 1991 0.75